Register Login

AnaptysBio Inc (ANAB)

Marquet Magda 🟡 adjusted position in 11.0K shares (1 derivative) of ANAPTYSBIO, INC (ANAB) at $48.85 ($1.1M) Transaction Date: Jan 15, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 2:26 p.m.

    🔍 Marquet Magda (Executive)

    Company: ANAPTYSBIO, INC (ANAB)

    Report Date: 2026-01-15

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 11,000
    • Total shares sold: 22,000

    Detailed Transactions and Holdings:

    • Acquired 11,000 shares of Common Stock at $26.11 per share (Direct)
      Date: 2026-01-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,930.00 | transaction_form_type: 4
    • Sold 9,290 shares of Common Stock at $48.1162 per share (Direct)
      Date: 2026-01-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,640.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,710 shares of Common Stock at $48.849 per share (Direct)
      Date: 2026-01-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,930.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 11,000 shares of Stock Option (right to buy) at $26.11 per share (Derivative)
      Date: 2026-01-15 | Code: M | Expires: 2031-01-17 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4

    Footnotes:

    • F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.595 to $48.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.625 to $48.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The stock option is fully vested.
    • F4: In addition to the options to purchase shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 70,104 shares of common stock, which options vest according to their terms.

Search

News categories